価格表

在庫・価格 : 2024年03月29日 05時09分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Progranulin, Human, ELISA Kit, Twin plex (2×96well)
データシート
AG-45A-0018YTP-KI01 KOMアディポジェン ライフ サイエンシーズ
Adipogen Life Sciences
1 kit ¥255,000
(未発注)
追加

在庫・価格 : 2024年03月29日 05時09分 現在

Progranulin, Human, ELISA Kit, Twin plex (2×96well)

  • 商品コード:AG-45A-0018YTP-KI01
  • メーカー:KOM
  • 包装:1kit
  • 価格: ¥255,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ghidoni R et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008 Oct;71(16):1235-9
Ghidoni R et al
2008/01/01
PubMed
2 Rademakers R et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008 Dec;17(23):3631-42
Rademakers R et al
2008/01/01
PubMed
3 Youn BS et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009 Mar;58(3):627-36
Youn BS et al
2009/01/01
PubMed
4 Finch N et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009 Mar;132(Pt 3):583-91
Finch N et al
2009/01/01
PubMed
5 Carecchio M et al. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer"s disease. J. Neurol. Sci. 2009 Dec;287(1
Carecchio M et al
2009/01/01
PubMed
6 De Riz M et al. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neurosci. Lett. 2010 Jan;469(2):234-6
De Riz M et al
2010/01/01
PubMed
7 Schofield EC et al. Low serum progranulin predicts the presence of mutations: a prospective study. J. Alzheimers Dis. 2010;22(3):981-4
Schofield EC et al
2010/01/01
PubMed
8 Rossi G et al. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. J. Alzheimers Dis. 2011;23(1):7-12
Rossi G et al
2011/01/01
PubMed
9 Wang J et al. Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J. Neurochem. 2010 Mar;112(5):1305-15
Wang J et al
2010/01/01
PubMed
10 Philips T et al. Microglial upregulation of progranulin as a marker of motor neuron degeneration. J. Neuropathol. Exp. Neurol. 2010 Dec;69(12):1191-200
Philips T et al
2010/01/01
PubMed
11 Hsiung GY et al. rs5848 polymorphism and serum progranulin level. J. Neurol. Sci. 2011 Jan;300(1-2):28-32
Hsiung GY et al
2011/01/01
PubMed
12 Cruchaga C et al. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 2011 May;68(5):581-6
Cruchaga C et al
2011/01/01
PubMed
13 Vercellino M et al. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis. Mult. Scler. 2011 Oct;17(10):1194-201
Vercellino M et al
2011/01/01
PubMed
14 Steinacker P et al. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis. PLoS ONE 2011;6(8):e23600
Steinacker P et al
2011/01/01
PubMed
15 Boss湛 P et al. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation 2011;8:65
Boss湛 P et al
2011/01/01
PubMed
16 Wex T et al. Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression. BMC Gastroenterol 2011;11:63
Wex T et al
2011/01/01
PubMed
17 Pietroboni AM et al. Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. J. Alzheimers Dis. 2011;24(2):253-9
Pietroboni AM et al
2011/01/01
PubMed
18 Bagnoli S et al. Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. Cell. Mol. Neurobiol. 2012 Jan;32(1):13-6
Bagnoli S et al
2012/01/01
PubMed
19 Ghidoni R et al. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. Neurodegener Dis 2012;9(3):121-7
Ghidoni R et al
2012/01/01
PubMed
20 Gilberti N et al. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study. Neurol. Sci. 2012 Aug;33(4):899-904
Gilberti N et al
2012/01/01
PubMed
21 Borroni B et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol. Aging 2012 Oct;33(10):2506-20
Borroni B et al
2012/01/01
PubMed
22 Loei H et al. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J. Proteome Res. 2012 Mar;11(3):1759-72
Loei H et al
2012/01/01
PubMed
23 Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
Bl端her M et al
2012/01/01
PubMed
24 Dols-Icardo O et al. Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Neurobiol. Aging 2012 Aug;33(8):1851.e17-9
Dols-Icardo O et al
2012/01/01
PubMed
25 Smith KR et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012 Jun;90(6):1102-7
Smith KR et al
2012/01/01
PubMed
26 Wojtas A et al. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis 2012;1(1):107-18
Wojtas A et al
2012/01/01
PubMed
27 Koo DH et al. Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study. PLoS ONE 2012;7(6):e39880
Koo DH et al
2012/01/01
PubMed
28 Taipa R et al. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia. J. Alzheimers Dis. 2012;30(1):83-90
Taipa R et al
2012/01/01
PubMed
29 Arighi A et al. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J. Alzheimers Dis. 2012;31(2):447-52
Arighi A et al
2012/01/01
PubMed
30 Antonell A et al. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer"s disease: detection of GRN mutations in a Spanish cohort. J. Alzheimers Dis. 2012;31(3):581-91
Antonell A et al
2012/01/01
PubMed
31 Todoric J et al. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy. Eur. J. Endocrinol. 2012 Oct;167(4):561-7
Todoric J et al
2012/01/01
PubMed
32 Bernardi L et al. Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy. Neurobiol. Aging 2012 Dec;33(12):2948.e1-2948.e10
Bernardi L et al
2012/01/01
PubMed
33 Chen-Plotkin AS et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J. Neurosci. 2012 Aug;32(33):11213-27
Chen-Plotkin AS et al
2012/01/01
PubMed
34 Alquezar C et al. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol. Aging 2012 Feb;33(2):429.e7-20
Alquezar C et al
2012/01/01
PubMed
35 Jin SC et al. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer"s disease Ibero-American cohort. Alzheimers Res Ther 2012;4(4):34
Jin SC et al
2012/01/01
PubMed
36 Bozzali M et al. Structural brain signature of FTLD driven by Granulin mutation. J. Alzheimers Dis. 2013;33(2):483-94
Bozzali M et al
2013/01/01
PubMed
37 Thurner L et al. Progranulin antibodies in autoimmune diseases. J. Autoimmun. 2013 May;42:29-38
Thurner L et al
2013/01/01
PubMed
38 Galimberti D et al. Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration. Neurol. Sci. 2013 Jun;34(6):899-903
Galimberti D et al
2013/01/01
PubMed
39 K辰m辰l辰inen A et al. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer"s disease patients. J. Alzheimers Dis. 2013;33(1):23-7
K辰m辰l辰inen A et al
2013/01/01
PubMed
40 Yoo HJ et al. Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS ONE 2013;8(2):e55744
Yoo HJ et al
2013/01/01
PubMed
41 Rodr鱈guez-Rodr鱈guez E et al. Screening for progranulin mutations by serum protein dosage in common neurodegenerative disorders. Parkinsonism Relat. Disord. 2013 Aug;19(8):768-9
Rodr鱈guez-Rodr鱈guez E et al
2013/01/01
PubMed
42 Chiang HH et al. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration. Eur. J. Hum. Genet. 2013 Nov;21(11):1260-5
Chiang HH et al
2013/01/01
PubMed
43 Thurner L et al. Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Res. Ther. 2013;15(6):R211
Thurner L et al
2013/01/01
PubMed
44 Mirzaei K et al. Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetol Metab Syndr 2013;5(1):79
Mirzaei K et al
2013/01/01
PubMed
45 Choi KM et al. Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc Diabetol 2014;13:14
Choi KM et al
2014/01/01
PubMed
46 Tanaka Y et al. Circulating progranulin level is associated with visceral fat and elevated liver enzymes: Significance of serum progranulin as a useful marker for liver dysfunction. Endocr. J. 2014 Sep;
Tanaka Y et al
2014/01/01
PubMed
47 Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
Flehmig G et al
2014/01/01
PubMed
48 Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
Cerezo LA et al
2015/01/01
PubMed
49 Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
Cerezo LA et al
2015/01/01
PubMed
50 Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
Cerezo LA et al
2015/01/01
PubMed
51 Karch CM et al. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features. Neurobiol Aging 2016 Feb;38:215.e1-215.e12
Karch CM et al
2016/01/01
PubMed
52 Feneberg E et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna) 2016 Mar;123(3):289-96
Feneberg E et al
2016/01/01
PubMed
53 Aswathy PM et al. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia. Neurobiol Aging 2016 Mar;39:218.e1-3
Aswathy PM et al
2016/01/01
PubMed
54 Piscopo P et al. Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia. Front Mol Neurosci 2016;9:31
Piscopo P et al
2016/01/01
PubMed
55 Nicholson AM et al. Prosaposin is a regulator of progranulin levels and oligomerization. Nat Commun 2016 Jun;7:11992
Nicholson AM et al
2016/01/01
PubMed
56 Johnson J et al. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol 2017 Mar;36(3):507-516
Johnson J et al
2017/01/01
PubMed
57 Goossens J et al. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimers Res Ther 2018 03;10(1):31
Goossens J et al
2018/01/01
PubMed
58 Sellami L et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging 2020 07;91:167.e1-167.e9
Sellami L et al
2020/01/01
PubMed
59 Bruzova M et al. Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Sci Rep 2021 05;11(1):10837
Bruzova M et al
2021/01/01
PubMed
60 Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
Then C et al
2022/01/01
PubMed
61 Cheung PF et al. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Nat Commun 2022 01;13(1):156
Cheung PF et al
2022/01/01
PubMed
62 Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
Cerezo LA et al
2015/01/01
PubMed
63 Karch CM et al. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features. Neurobiol Aging 2016 Feb;38:215.e1-215.e12
Karch CM et al
2016/01/01
PubMed
64 Feneberg E et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna) 2016 Mar;123(3):289-96
Feneberg E et al
2016/01/01
PubMed
65 Aswathy PM et al. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia. Neurobiol Aging 2016 Mar;39:218.e1-3
Aswathy PM et al
2016/01/01
PubMed
66 Piscopo P et al. Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia. Front Mol Neurosci 2016;9:31
Piscopo P et al
2016/01/01
PubMed
67 Nicholson AM et al. Prosaposin is a regulator of progranulin levels and oligomerization. Nat Commun 2016 Jun;7:11992
Nicholson AM et al
2016/01/01
PubMed
68 Johnson J et al. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol 2017 Mar;36(3):507-516
Johnson J et al
2017/01/01
PubMed
69 Goossens J et al. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimers Res Ther 2018 03;10(1):31
Goossens J et al
2018/01/01
PubMed
70 Sellami L et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging 2020 07;91:167.e1-167.e9
Sellami L et al
2020/01/01
PubMed
71 Bruzova M et al. Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Sci Rep 2021 05;11(1):10837
Bruzova M et al
2021/01/01
PubMed
72 Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
Then C et al
2022/01/01
PubMed
73 Cheung PF et al. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Nat Commun 2022 01;13(1):156
Cheung PF et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ghidoni R et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008 Oct;71(16):1235-9
    Ghidoni R et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rademakers R et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008 Dec;17(23):3631-42
    Rademakers R et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Youn BS et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009 Mar;58(3):627-36
    Youn BS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Finch N et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009 Mar;132(Pt 3):583-91
    Finch N et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Carecchio M et al. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer"s disease. J. Neurol. Sci. 2009 Dec;287(1
    Carecchio M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    De Riz M et al. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neurosci. Lett. 2010 Jan;469(2):234-6
    De Riz M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Schofield EC et al. Low serum progranulin predicts the presence of mutations: a prospective study. J. Alzheimers Dis. 2010;22(3):981-4
    Schofield EC et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Rossi G et al. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. J. Alzheimers Dis. 2011;23(1):7-12
    Rossi G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wang J et al. Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J. Neurochem. 2010 Mar;112(5):1305-15
    Wang J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Philips T et al. Microglial upregulation of progranulin as a marker of motor neuron degeneration. J. Neuropathol. Exp. Neurol. 2010 Dec;69(12):1191-200
    Philips T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Hsiung GY et al. rs5848 polymorphism and serum progranulin level. J. Neurol. Sci. 2011 Jan;300(1-2):28-32
    Hsiung GY et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Cruchaga C et al. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 2011 May;68(5):581-6
    Cruchaga C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Vercellino M et al. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis. Mult. Scler. 2011 Oct;17(10):1194-201
    Vercellino M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Steinacker P et al. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis. PLoS ONE 2011;6(8):e23600
    Steinacker P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Boss湛 P et al. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation 2011;8:65
    Boss湛 P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Wex T et al. Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression. BMC Gastroenterol 2011;11:63
    Wex T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Pietroboni AM et al. Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. J. Alzheimers Dis. 2011;24(2):253-9
    Pietroboni AM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Bagnoli S et al. Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. Cell. Mol. Neurobiol. 2012 Jan;32(1):13-6
    Bagnoli S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Ghidoni R et al. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. Neurodegener Dis 2012;9(3):121-7
    Ghidoni R et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Gilberti N et al. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study. Neurol. Sci. 2012 Aug;33(4):899-904
    Gilberti N et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Borroni B et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol. Aging 2012 Oct;33(10):2506-20
    Borroni B et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Loei H et al. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J. Proteome Res. 2012 Mar;11(3):1759-72
    Loei H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
    Bl端her M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Dols-Icardo O et al. Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Neurobiol. Aging 2012 Aug;33(8):1851.e17-9
    Dols-Icardo O et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Smith KR et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012 Jun;90(6):1102-7
    Smith KR et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Wojtas A et al. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis 2012;1(1):107-18
    Wojtas A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Koo DH et al. Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study. PLoS ONE 2012;7(6):e39880
    Koo DH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Taipa R et al. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia. J. Alzheimers Dis. 2012;30(1):83-90
    Taipa R et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Arighi A et al. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. J. Alzheimers Dis. 2012;31(2):447-52
    Arighi A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Antonell A et al. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer"s disease: detection of GRN mutations in a Spanish cohort. J. Alzheimers Dis. 2012;31(3):581-91
    Antonell A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Todoric J et al. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy. Eur. J. Endocrinol. 2012 Oct;167(4):561-7
    Todoric J et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Bernardi L et al. Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy. Neurobiol. Aging 2012 Dec;33(12):2948.e1-2948.e10
    Bernardi L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Chen-Plotkin AS et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J. Neurosci. 2012 Aug;32(33):11213-27
    Chen-Plotkin AS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Alquezar C et al. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol. Aging 2012 Feb;33(2):429.e7-20
    Alquezar C et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Jin SC et al. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer"s disease Ibero-American cohort. Alzheimers Res Ther 2012;4(4):34
    Jin SC et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Bozzali M et al. Structural brain signature of FTLD driven by Granulin mutation. J. Alzheimers Dis. 2013;33(2):483-94
    Bozzali M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Thurner L et al. Progranulin antibodies in autoimmune diseases. J. Autoimmun. 2013 May;42:29-38
    Thurner L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Galimberti D et al. Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration. Neurol. Sci. 2013 Jun;34(6):899-903
    Galimberti D et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    K辰m辰l辰inen A et al. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer"s disease patients. J. Alzheimers Dis. 2013;33(1):23-7
    K辰m辰l辰inen A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Yoo HJ et al. Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS ONE 2013;8(2):e55744
    Yoo HJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Rodr鱈guez-Rodr鱈guez E et al. Screening for progranulin mutations by serum protein dosage in common neurodegenerative disorders. Parkinsonism Relat. Disord. 2013 Aug;19(8):768-9
    Rodr鱈guez-Rodr鱈guez E et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Chiang HH et al. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration. Eur. J. Hum. Genet. 2013 Nov;21(11):1260-5
    Chiang HH et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Thurner L et al. Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Res. Ther. 2013;15(6):R211
    Thurner L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Mirzaei K et al. Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetol Metab Syndr 2013;5(1):79
    Mirzaei K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Choi KM et al. Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc Diabetol 2014;13:14
    Choi KM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Tanaka Y et al. Circulating progranulin level is associated with visceral fat and elevated liver enzymes: Significance of serum progranulin as a useful marker for liver dysfunction. Endocr. J. 2014 Sep;
    Tanaka Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
    Flehmig G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
    Cerezo LA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
    Cerezo LA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
    Cerezo LA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Karch CM et al. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features. Neurobiol Aging 2016 Feb;38:215.e1-215.e12
    Karch CM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Feneberg E et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna) 2016 Mar;123(3):289-96
    Feneberg E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Aswathy PM et al. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia. Neurobiol Aging 2016 Mar;39:218.e1-3
    Aswathy PM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Piscopo P et al. Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia. Front Mol Neurosci 2016;9:31
    Piscopo P et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Nicholson AM et al. Prosaposin is a regulator of progranulin levels and oligomerization. Nat Commun 2016 Jun;7:11992
    Nicholson AM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Johnson J et al. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol 2017 Mar;36(3):507-516
    Johnson J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Goossens J et al. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimers Res Ther 2018 03;10(1):31
    Goossens J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Sellami L et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging 2020 07;91:167.e1-167.e9
    Sellami L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Bruzova M et al. Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Sci Rep 2021 05;11(1):10837
    Bruzova M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
    Then C et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Cheung PF et al. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Nat Commun 2022 01;13(1):156
    Cheung PF et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Cerezo LA et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015;2015:740357
    Cerezo LA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Karch CM et al. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features. Neurobiol Aging 2016 Feb;38:215.e1-215.e12
    Karch CM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Feneberg E et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna) 2016 Mar;123(3):289-96
    Feneberg E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Aswathy PM et al. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia. Neurobiol Aging 2016 Mar;39:218.e1-3
    Aswathy PM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Piscopo P et al. Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia. Front Mol Neurosci 2016;9:31
    Piscopo P et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Nicholson AM et al. Prosaposin is a regulator of progranulin levels and oligomerization. Nat Commun 2016 Jun;7:11992
    Nicholson AM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Johnson J et al. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol 2017 Mar;36(3):507-516
    Johnson J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Goossens J et al. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimers Res Ther 2018 03;10(1):31
    Goossens J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Sellami L et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging 2020 07;91:167.e1-167.e9
    Sellami L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Bruzova M et al. Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Sci Rep 2021 05;11(1):10837
    Bruzova M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
    Then C et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Cheung PF et al. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Nat Commun 2022 01;13(1):156
    Cheung PF et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed